Kevin Patrick Moran, SVP, CFO & Treasurer at Vanda Pharmaceuticals Inc. (VNDA), bought 2,000 shares at $4.39 ($9K) on 2025-02-21, disclosed to the SEC on 2025-02-24.
Open-market purchase of $9k VNDA by SVP, CFO & Treasurer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| VNDA | SELL | 2024-03-06 | $63K | — | Filing → |
| VNDA | SELL | 2023-08-01 | $14K | — | Filing → |
| VNDA | SELL | 2023-06-20 | $101K | — | Filing → |